The Blood manufacturing community began implementation of NucleicAcidAmplification Testing (NAAT) under the FDA's Investigational New Drug (IND) application process.
血液制造商开始根据FDA的研究性新药(IND)申请程序执行核酸检测(NAAT)。
2
Objective To detect the status of CT and UU infection in local (STD)patients, and the value of measuring CT and UU with NucleicAcidAmplification Hybridization Climb method.
The present invention further provides nucleicacid molecules for use as molecular probes, or as primers for polymerase chain reaction (PCR) amplification, i. e. synthetic or natural oligonucleotides.